Sources MOUNJARO (tirzepatide) Injection, for subcutaneous use (2022) Zepbound (tirzepatide) Injection, for subcutaneous use (2022) Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022) Lilly Launches Additional Zepbound Vial Doses and Offers New Savings for Self-Pay Patients (February 25, 2025) LillyDirect: Zepbound (Accessed: May 21, 2025) Savings & Support for Mounjaro (Accessed: May 21, 2025) Medicare Coverage of GLP-1 Drugs (Accessed: May 21, 2025)
How Do Ozempic (Semaglutide GLP-1) Injections Support Medical Weight Loss Beyond Appetite Control
Side-effect logging is free in full: the 18 most common GLP-1 side effects plus unlimited custom symptoms, each on a 0-10 severity scale with timestamps, so a rough week becomes a record instead of a vague memory
The most common are 5mg/mL, 10mg/mL, and 20mg/mL
Relaxation training helps the patient get ready for sleep by ensuring relaxed muscles, deep quiet breathing, and focusing the mind instead of letting it race or wander, leading to further arousal